Press Releases

Press Releases

April 1, 2019
NEWPORT BEACH, Calif. , April 01, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced it expects the European Medicines Agency (EMA) Committee for Medicinal Products for
March 18, 2019
Received U.S. FDA Approval of Jeuveau™ on February 1, 2019 Majority of Sales Force Hired with Launch Planned in the Coming Weeks Hosting Investor & Analyst Day on May 8 th , 2019 in New York, NY NEWPORT BEACH, Calif. , March 18, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc.
Displaying 11 - 18 of 18